Berberine protects against sepsis-related acute lung injury in rats
Data files
Nov 10, 2021 version files 125.19 KB
-
Draft.docx
12.37 KB
-
statistics.docx
112.82 KB
Feb 16, 2022 version files 113.14 KB
-
README.md
318 B
-
statistics.docx
112.82 KB
Abstract
Aim: To assess the therapeutic effects of berberine in experimentally induced lung sepsis. Examining its effects on selected cytokines, gene and protein expression and the histopathological findings.
Results: Berberine significantly reduced the wet/dry lung ratio, the BALF protein, cell, and neutrophils percentage & the BALF cytokines levels. In addition, pretreatment with berberine decreases the myeloperoxidase and MDA levels and decreases gene expression of NFKB, MCP -1 and the ICAM - 1 by RT - PCR analysis. Thus, suggesting an antioxidant and anti-inflammatory mode of the action. Western blot analysis revealed increased PPAR – Υ expression in the berberine pretreated group compared to the CLP group. Histopathological examination revealed improved histopathological parameters, in the berberine pretreated group, compared to the CLP group.
Conclusion: Berberine improves the outcome in sepsis via antioxidant and anti-inflammatory effects, modulation of cytokine levels, upregulation of PPAR - Υ protein expression, and histopathological amelioration.
README: Berberine protects against sepsis-related acute lung injury in rats
https://doi.org/10.5061/dryad.mkkwh711p
Give a brief summary of dataset contents, contextualized in experimental procedures and results.
Description of the data and file structure
One data file statistics.docx with tables and figures.